Skip to main content

Advertisement

Log in

Regional cerebral glucose metabolism and postmortem pathology in Alzheimer’s disease

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

In four patients with an antemortem diagnosis of probable Alzheimer’s disease (AD) regional cerebral glucose metabolism (rCMRGl) was studied prospectively by positron emission tomography (PET) and compared with postmortem semiquantitative neuropathology. The interval between the last PET study and autopsy was 1.3±0.8 years. In comparison with age-matched controls, the AD patients showed predominant temporoparietal hypometabolism spreading to other cortical and subcortical regions during serial PET scans. All patients had neuropathological findings typical for AD. There was a significant relationship between rCMRGl and density of senile plaques (SP) in one patient (τ = -0.86, P < 0.05). SP were distributed quite homogeneously in all regions examined. Neurofibrillary tangles (NFT) were concentrated focally in the hippocampus-amygdala-entorhinal complex. In the context of widespread developing cortical hypometabolism, the predilection of NFT for involvement in limbic areas suggests a disruption of projection neurons as the pathogenetic process of cortical dysfunction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Arnold SE, Hyman TB, Flory J, Damasio AR, Van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex 1: 103–116

    Article  PubMed  CAS  Google Scholar 

  2. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42: 631–639

    PubMed  CAS  Google Scholar 

  3. Benson DF, Kuhl DE, Hawkins RA, Phelps ME, Cummings JL, Tsai SY (1983) The fluordeoxyglucose 18F scan in Alzheimer’s disease and multi-infarct dementia. Arch Neurol 40: 711–714

    PubMed  CAS  Google Scholar 

  4. Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114: 797–811

    Article  PubMed  CAS  Google Scholar 

  5. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239–259

    Article  PubMed  CAS  Google Scholar 

  6. Burns A, Luthert P, Levy R, Jacoby R, Lantos P (1990) Accuracy of clinical diagnosis of Alzheimer’s disease. BMJ 301: 1026

    Article  PubMed  CAS  Google Scholar 

  7. Chase TN, Foster NL, Mansi L (1983) Alzheimer’s disease and the parietal lobe. Lancet II: 225

    Article  Google Scholar 

  8. Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu J, Kawas C, Aronson M, Wolfson L (1988) Clinicopathologic studies in dementia: nondemented subjects with confirmed Alzheimer’s disease. Neurology 38: 1682–1688

    PubMed  CAS  Google Scholar 

  9. DeCarli C, Atack JR, Ball MJ, Kay JA, Grady CL, Fewster P, Pettigrew KD, Rapoport SI, Schapiro MB (1992) Post-mortem neurofibrillary tangle densities but not senile plaques densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer’s disease patients. Neurodegeneration 1: 113–121

    Google Scholar 

  10. Dekosky ST, Scheff SW (1990) Synapse loss in frontal-cortex biopsies in Alzheimer’s disease — correlation with cognitive severity. Ann Neurol 27: 457–464

    Article  PubMed  CAS  Google Scholar 

  11. Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ (1991) Subtypes and differential laminar distributions of beta A4 deposits in Alzheimer’s disease: relationship with the intellectual status of 26 cases. Acta Neuropathol 81: 328–335

    Article  PubMed  CAS  Google Scholar 

  12. Dewar D, Wyper D, Graham DI, McCulloch J (1991) Regional cerebral blood flow and quantitative neuropathology in autopsy-verified cases of Alzheimer’s disease. J Cereb Blood Flow Metab 11: 18

    Google Scholar 

  13. Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, Moore A, Schlageter N, Rapoport SI (1986) Positron emission tomography in Alzheimer’s disease. Neurology 36: 879–887

    PubMed  CAS  Google Scholar 

  14. Duara R, Barker WW, Pascal S, Bruce-Grgorios J, Nuremberg M, Boothe T (1991) Lack of correlation of regional neuropathology to the regional PET metabolic deficits in Alzheimer’s disease. J Cereb Blood Flow Metab 11: 19

    Google Scholar 

  15. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. J Psychiatr Res 12: 189–198

    Article  PubMed  CAS  Google Scholar 

  16. Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, DiChiro G (1983) Alzheimer’s disease: focal cortical changes shown by positron emission tomography. Neurology 33: 961–965

    PubMed  CAS  Google Scholar 

  17. Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, Ober BO, Huesman RH, Derenzo SE (1983) Regional cerebral metabolic alterations in dementia of the Alzheimer’s type: positron emission tomography with (18F)fluordeoxyglucose. J Comput Assist Tomogr 7: 595–598

    Article  Google Scholar 

  18. Galasko D, Hansen LA, Katzman R, Wiederholt W, Masliah E, Terry R, Hill R, Lessin P, Thal LJ (1994) Clinical-neuropathological correlations in Alzheimer’s disease and related dementias. Arch Neurol 51: 888–895

    PubMed  CAS  Google Scholar 

  19. Herholz K, Pawlik G, Wienhard K, Heiss WD (1985) Computer assisted mapping in quantitative analysis of cerebral positron emission tomography. J Comput Assist Tomogr 9: 154–161

    Article  PubMed  CAS  Google Scholar 

  20. Herholz K, Adams R, Kessler J, Szelies B, Grond M, Heiss WD (1990) Accuracy of diagnosis of Alzheimer’s disease with positron emission tomography. Dementia 1: 156–164

    Google Scholar 

  21. Hyman BT, Van Hoesen GW, Damasio AR (1990) Memory-relatedneural systems in Alzheimer’s disease: an anatomical study. Neurology 40: 1721–1730

    PubMed  CAS  Google Scholar 

  22. Kennedy AM, Newman S, Clegg F, Tyrrell P, Warrington EK, Roques P, Hardy J, Rossor MN, Frackowiak RSJ (1992) Imaging in dementia: longitudinal studies using positron emission tomography. Neurobiol Aging 13:13

    Article  Google Scholar 

  23. Khachaturian AZ (1985) Diagnosis of Alzheimer’s disease. Arch Neurol 42: 1097–1104

    PubMed  CAS  Google Scholar 

  24. Martin EM, Wilson RS, Penn RD, Fox JH, Clasen RA, Savoy RN (1987) Cortical biopsy results in Alzheimer’s disease: correlation with cognitive deficits. Neurology 37: 1201–1204

    PubMed  CAS  Google Scholar 

  25. McGeer PL, Kamo H, Harrop R, McGeer EG, Martin WRW, Pate BD, Li DKB (1986) Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer’s disease. Neurology 36: 1569–1574

    PubMed  CAS  Google Scholar 

  26. McGeer PL, Kamo H, Harrop R, Li DKB, Tuokko H, McGeer EG, Adam MJ, Ammann W (1986) Positron emission tomography in patients with clinical diagnosed Alzheimer’s disease. Can Med Assoc J 134: 597–607

    CAS  Google Scholar 

  27. McGeer EG, McGeer PL, Harrop R, Akiyama H, Kamo H (1990) Correlations of regional postmortem enzyme activities with premortem local glucose metabolic rates in Alzheimer’s disease. J Neurosci Res 27: 612–619

    Article  PubMed  CAS  Google Scholar 

  28. McGeer PL, McGeer EG, Akiyama H, Harrop R (1990) Regional deficits in cortical metabolism in PET-scanned Alzheimer cases correlate with postmortem biochemical indices of gliosis and not with choline acetyltransferase. Neurobiol Aging 11:260–261

    Google Scholar 

  29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 19: 939–944

    Google Scholar 

  30. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD (1992) Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type. Neurobiol Aging 13: 93–98

    Article  PubMed  CAS  Google Scholar 

  31. Mielke R, Herholz K, Grond M, Kessler J, Heiss WD (1994) Clinical deterioration in probable Alzheimer’s disease correlates with progressive metabolic impairment of association areas. Dementia 5: 36–41

    PubMed  CAS  Google Scholar 

  32. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer’s disease (CERAD). II. Standardization of the neuropathological assessment of Alzheimer’s disease. Neurology 41: 479–486

    PubMed  CAS  Google Scholar 

  33. Morris JC, McKeel DW Jr, Fulling K, Torack RM, Berg L (1988) Validation of clinical diagnostic criteria for Alzheimer’s disease. Ann Neurol 24: 17–22

    Article  PubMed  CAS  Google Scholar 

  34. Neary D, Snowdon JS, Mann DMA, Bowen DM, Sims NR, Northern B, Yates PO, Davidson AN (1989) Alzheimer’s disease: a correlative study. J Neurol Neurosurg Psychiatry 49: 229–237

    Article  Google Scholar 

  35. Powers JM, Sclaepfer WW, Willingham MC, Hall BJ (1981) An immunoperoxidase study of senile cerebral amyloidosis with pathogenetic considerations. J Neuropathol Exp Neurol 40: 592–612

    Article  PubMed  CAS  Google Scholar 

  36. Reisberg B, Ferris SH, De Leon MJ, Crook T (1982) The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 139: 1136–1139

    Google Scholar 

  37. Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps ME, Ido T, Casella V, Fowler J, Hoffman E, Alavi A, Som P, Sokoloff L (1979) The (18F)fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44: 127–137

    PubMed  CAS  Google Scholar 

  38. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28: 897–916

    Article  PubMed  CAS  Google Scholar 

  39. Sulkava R, Haltia M, Paetau A, Wilkström J, Palo J (1983) Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry 46: 9–13

    Article  PubMed  CAS  Google Scholar 

  40. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer’s disease — synapse loss is the major correlate of cognitive impairment. Ann Neurol 30: 572–580

    Article  PubMed  CAS  Google Scholar 

  41. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P (1988) The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer’s disease. A clinicopathologic study of 57 cases. Neurology 38: 359–364

    PubMed  CAS  Google Scholar 

  42. Wienhard K, Pawlik G, Herholz K, Wagner R, Heiss WD (1985) Estimation of local cerebral glucose utilization by positron emission tomography of (18F)-2-fluoro-2-deoxy-d-glucose: a critical appraisal of optimization procedures. J Cereb Blood Flow Metab 5: 115–125

    PubMed  CAS  Google Scholar 

  43. Wilcock GK, Esiri MM (1982) Plaques, tangles and dementia. A quantitative study. J Neurol Sci 57: 407–417

    Article  PubMed  CAS  Google Scholar 

  44. Wisniewski HM, Moretz RC, Lossinsky AS (1981) Evidence for induction of localized amyloid deposits and neuritic plaques by an infectious agent. Ann Neurol 10: 517–522

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mielke, R., Schröder, R., Fink, G.R. et al. Regional cerebral glucose metabolism and postmortem pathology in Alzheimer’s disease. Acta Neuropathol 91, 174–179 (1996). https://doi.org/10.1007/s004010050410

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004010050410

Key words

Navigation